Felodipine re-positioned as a neuroprotectant via improved optic nerve head blood circulation in retinal ischemic rabbits and ocular hypertensive rats
Taniguchi T, Akaishi T, Hata T, Yamashita R, Esaki Y, Morofuji R, Okabe K, Fuwa M, Yamamoto Y, Guo L, Choi S, Luong V, Ota T, Sharif NA, Cordeiro MF, Kageyama M.
View publication
-
Therapeutic Area
Glaucoma
-
Categories
Preclinical development
-
Affiliations
Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd, 8916-16 Takayama-cho, Ikoma-shi, 630 - 0101, Nara, Japan. takazumi.taniguchi@santen.com; Product Development Division, Santen Pharmaceutical Co., Ltd, Ikoma-shi, Nara, Japan; Institute of Ophthalmology, University College London (UCL), London, UK; Novai Ltd, Work Life, The White Building, 33 King's Road, Reading, RG1 3AR, UK; Ophthalmology Innovation Center, Santen Pharmaceutical Co., Ltd, 8916-16 Takayama-cho, Ikoma-shi, 630 - 0101, Nara, Japan; Ophthalmology Innovation Center, Santen Inc, Emeryville, CA, USA; Eye-APC Duke-NUS Medical School, Singapore, Singapore; Department of Pharmacy Sciences, Creighton University, Omaha, NE, USA; Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, Texas Southern University, Houston, TX, USA; Department of Pharmacology and Neuroscience, University of North Texas Health Sciences Center, Fort Worth, TX, USA; Singapore Eye Research Institute, Singapore, 169856, Singapore; Imperial College of Science and Technology, St. Mary's Campus, London, UK